Announced
Completed
Financials
Tags
Private
Majority
Single Bidder
Friendly
Domestic
Acquisition
Electronic Components and Equipment
chemical technology
United States
Completed
Synopsis
Cambrex, a global contract development and manufacturing organization, completed the acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Financial terms were not disclosed. “We are excited to be joining Cambrex, a company with over 40 years of drug substance development and manufacturing expertise. Partnering our best-in-class process development capabilities with Cambrex’s larger scale manufacturing facilities in North America and Europe is a natural fit, both for our employees and our customers," Matt Bio, Snapdragon CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.